Sanofi's Dupixent gets Europe eczema nod
admin 28th September 2017 Uncategorised 0Drug becomes first targeted biologic in Europe to treat moderate-to-severe atopic dermatitis (AP)
More: Sanofi's Dupixent gets Europe eczema nod
Source: News
Drug becomes first targeted biologic in Europe to treat moderate-to-severe atopic dermatitis (AP)
More: Sanofi's Dupixent gets Europe eczema nod
Source: News
© 1994 - 2025 B.M. Pharmaceuticals